Literature DB >> 25568870

It is time to integrate conventional therapy by ozone therapy in type-2 diabetes patients.

Velio Bocci1, Iacopo Zanardi1, Maya S P Huijberts1, Valter Travagli1.   

Abstract

Entities:  

Year:  2014        PMID： 25568870      PMCID： PMC4260055          DOI： 10.3978/j.issn.2305-5839.2014.07.07

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  5 in total

Review 1.  Oxidative stress and diabetic neuropathy: a new understanding of an old problem.

Authors:  Eva L Feldman
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  NRF2 activation is involved in ozonated human serum upregulation of HO-1 in endothelial cells.

Authors:  Alessandra Pecorelli; Velio Bocci; Alessandra Acquaviva; Giuseppe Belmonte; Concetta Gardi; Fabio Virgili; Lucia Ciccoli; Giuseppe Valacchi
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-16       Impact factor: 4.219

Review 3.  Free radicals and antioxidants: how to reestablish redox homeostasis in chronic diseases?

Authors:  V Bocci; G Valacchi
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  Changes in diabetes-related complications in the United States, 1990-2010.

Authors:  Edward W Gregg; Yanfeng Li; Jing Wang; Nilka Rios Burrows; Mohammed K Ali; Deborah Rolka; Desmond E Williams; Linda Geiss
Journal:  N Engl J Med       Date:  2014-04-17       Impact factor: 91.245

5.  An integrated medical treatment for type-2 diabetes.

Authors:  Velio Bocci; Iacopo Zanardi; Maya S P Huijberts; Valter Travagli
Journal:  Diabetes Metab Syndr       Date:  2013-11-15
  5 in total
  2 in total

Review 1.  Expert consensus of Chinese Association for the Study of Pain on the application of ozone therapy in pain medicine.

Authors:  Zhi-Gang Zhuang; Li-Juan Lu; Bao-Gan Peng; Ke Ma; Zhen-Yu Cai; Zhi-Jian Fu; Guang-Zhao Liu; Jin-Feng Liu; Wen-Tao Liu; Xiao-Hong Li; Tao Song; Da-Sheng Wu; Jing Yao; Peng Yao; Jian-She Yu; Yan-Qing Liu
Journal:  World J Clin Cases       Date:  2021-03-26       Impact factor: 1.337

2.  A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial.

Authors:  Alok Sharma; Mili Shah; Satya Lakshmi; Hemangi Sane; Jignasha Captain; Nandini Gokulchandran; Pallavi Khubchandani; M K Pradeep; Prakash Gote; Balaji Tuppekar; Pooja Kulkarni; Amruta Paranjape; Radhika Pradhan; Ritu Varghese; Sushil Kasekar; Vivek Nair; Ummeammara Khanbande
Journal:  Int Immunopharmacol       Date:  2021-04-30       Impact factor: 5.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.